We can’t show the full text here under this license.
Abstract
The intravenous delivery of cytidine base editors achieved ~21% on-target editing in the liver of mice with phenylketonuria without off-target mutations.
- Cytidine base editors are capable of precise single-base modifications in genomic DNA.
- Off-target activity poses a significant concern for the therapeutic use of base editors.
- In this study, no off-target edits were detected in the RNA or DNA of liver cells.
- The editing process led to the repair of the mutation responsible for phenylketonuria.
- Transitory expression of base editor components resulted in a reversal of the disease phenotype.
Simplified